# Phillips Edison & Company, Inc.: financial statements, quarterly

PECO · Nasdaq · CIK 1476204 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/peco.md) · [Financials](/companies/peco/financials.md) · [Filings](/companies/peco/filings.md) · [Insiders](/companies/peco/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/peco/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [2.2](/filings/0001476204-24-000111.md) | [2.5 d](/filings/0001476204-26-000005.md) | [2.6](/filings/0001476204-25-000065.md) | [2.5](/filings/0001476204-25-000092.md) | [2.9](/filings/0001476204-25-000108.md) | [2.8 d](/filings/0001476204-26-000005.md) | [2.8](/filings/0001476204-26-000024.md) | [3.3](/filings/0001476204-26-000032.md) | [3.3](/filings/0001476204-25-000108.md) | [3.4 d](/filings/0001476204-26-000005.md) | [3.4](/filings/0001476204-26-000024.md) | [4.1](/filings/0001476204-26-000032.md) |
| Operating income | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Interest expense | $m | [21.5](/filings/0001476204-23-000129.md) | [22.6 d](/filings/0001476204-24-000022.md) | [23.3](/filings/0001476204-24-000055.md) | [23.6](/filings/0001476204-25-000092.md) | [25.0](/filings/0001476204-24-000111.md) | [25.0 d](/filings/0001476204-25-000030.md) | [25.7](/filings/0001476204-25-000065.md) | [27.7](/filings/0001476204-25-000092.md) | not reported | not reported | not reported | not reported |
| Income tax | $m | [0.1](/filings/0001476204-24-000111.md) | [0.0 d](/filings/0001476204-26-000005.md) | [0.1](/filings/0001476204-25-000065.md) | [0.5](/filings/0001476204-25-000092.md) | [0.4](/filings/0001476204-25-000108.md) | [0.8 d](/filings/0001476204-26-000005.md) | [0.1](/filings/0001476204-26-000024.md) | [0.2](/filings/0001476204-26-000032.md) | [0.2](/filings/0001476204-25-000108.md) | [0.7 d](/filings/0001476204-26-000005.md) | [0.2](/filings/0001476204-26-000024.md) | [0.2](/filings/0001476204-26-000032.md) |
| Net income | $m | [12.2](/filings/0001476204-24-000111.md) | [13.5 d](/filings/0001476204-26-000005.md) | [17.7](/filings/0001476204-25-000065.md) | [15.3](/filings/0001476204-25-000092.md) | [11.6](/filings/0001476204-25-000108.md) | [18.1 d](/filings/0001476204-26-000005.md) | [26.3](/filings/0001476204-26-000024.md) | [12.8](/filings/0001476204-26-000032.md) | [24.7](/filings/0001476204-25-000108.md) | [47.5 d](/filings/0001476204-26-000005.md) | [30.4](/filings/0001476204-26-000024.md) | [41.1](/filings/0001476204-26-000032.md) |
| Diluted EPS | $ per share | [0.10](/filings/0001476204-24-000111.md) | not reported | [0.14](/filings/0001476204-25-000065.md) | [0.12](/filings/0001476204-25-000092.md) | [0.09](/filings/0001476204-25-000108.md) | not reported | [0.21](/filings/0001476204-26-000024.md) | [0.10](/filings/0001476204-26-000032.md) | [0.20](/filings/0001476204-25-000108.md) | not reported | [0.24](/filings/0001476204-26-000024.md) | [0.33](/filings/0001476204-26-000032.md) |
| Basic EPS | $ per share | [0.10](/filings/0001476204-24-000111.md) | not reported | [0.14](/filings/0001476204-25-000065.md) | [0.12](/filings/0001476204-25-000092.md) | [0.09](/filings/0001476204-25-000108.md) | not reported | [0.21](/filings/0001476204-26-000024.md) | [0.10](/filings/0001476204-26-000032.md) | [0.20](/filings/0001476204-25-000108.md) | not reported | [0.24](/filings/0001476204-26-000024.md) | [0.33](/filings/0001476204-26-000032.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Operating income: not reported
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [3.8](/filings/0001476204-24-000111.md) | [4.9](/filings/0001476204-26-000005.md) | [5.6](/filings/0001476204-25-000065.md) | [7.1](/filings/0001476204-25-000092.md) | [6.4](/filings/0001476204-25-000108.md) | [4.9](/filings/0001476204-26-000005.md) | [5.5](/filings/0001476204-26-000024.md) | [5.6](/filings/0001476204-26-000032.md) | [4.1](/filings/0001476204-25-000108.md) | [3.5](/filings/0001476204-26-000032.md) | [3.1](/filings/0001476204-26-000024.md) | [7.1](/filings/0001476204-26-000032.md) |
| Total assets | $m | [4,718](/filings/0001476204-23-000129.md) | [4,866](/filings/0001476204-25-000030.md) | [4,887](/filings/0001476204-24-000055.md) | [4,907](/filings/0001476204-24-000099.md) | [4,950](/filings/0001476204-24-000111.md) | [5,046](/filings/0001476204-26-000005.md) | [5,162](/filings/0001476204-25-000065.md) | [5,269](/filings/0001476204-25-000092.md) | [5,262](/filings/0001476204-25-000108.md) | [5,286](/filings/0001476204-26-000032.md) | [5,351](/filings/0001476204-26-000024.md) | [5,445](/filings/0001476204-26-000032.md) |
| Total liabilities | $m | [2,111](/filings/0001476204-23-000129.md) | [2,212](/filings/0001476204-25-000030.md) | [2,249](/filings/0001476204-24-000055.md) | [2,292](/filings/0001476204-24-000099.md) | [2,371](/filings/0001476204-24-000111.md) | [2,412](/filings/0001476204-26-000005.md) | [2,541](/filings/0001476204-25-000065.md) | [2,675](/filings/0001476204-25-000092.md) | [2,683](/filings/0001476204-25-000108.md) | [2,697](/filings/0001476204-26-000032.md) | [2,771](/filings/0001476204-26-000024.md) | [2,777](/filings/0001476204-26-000032.md) |
| Long-term debt | $m | [1,870](/filings/0001476204-23-000129.md) | [1,969](/filings/0001476204-25-000030.md) | [2,016](/filings/0001476204-24-000055.md) | [2,042](/filings/0001476204-24-000099.md) | [2,105](/filings/0001476204-24-000111.md) | [2,110](/filings/0001476204-26-000005.md) | [2,278](/filings/0001476204-25-000065.md) | [2,393](/filings/0001476204-25-000092.md) | [2,385](/filings/0001476204-25-000108.md) | [2,375](/filings/0001476204-26-000032.md) | [2,489](/filings/0001476204-26-000024.md) | [2,451](/filings/0001476204-26-000032.md) |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [2,257](/filings/0001476204-23-000129.md) | [2,310](/filings/0001476204-25-000030.md) | [2,300](/filings/0001476204-24-000055.md) | [2,280](/filings/0001476204-24-000099.md) | [2,249](/filings/0001476204-24-000111.md) | [2,320](/filings/0001476204-26-000005.md) | [2,311](/filings/0001476204-25-000065.md) | [2,290](/filings/0001476204-25-000092.md) | [2,278](/filings/0001476204-25-000108.md) | [2,287](/filings/0001476204-26-000032.md) | [2,279](/filings/0001476204-26-000024.md) | [2,374](/filings/0001476204-26-000032.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Current portion of debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [88.6 d](/filings/0001476204-24-000111.md) | [72.0 d](/filings/0001476204-26-000005.md) | [63.1](/filings/0001476204-25-000065.md) | [78.5 d](/filings/0001476204-25-000092.md) | [109 d](/filings/0001476204-25-000108.md) | [84.0 d](/filings/0001476204-26-000005.md) | [60.5](/filings/0001476204-26-000024.md) | [96.1 d](/filings/0001476204-26-000032.md) | [95.4 d](/filings/0001476204-25-000108.md) | [96.1 d](/filings/0001476204-26-000005.md) | [55.6](/filings/0001476204-26-000024.md) | [118 d](/filings/0001476204-26-000032.md) |
| Dividends paid | $m | [34.0 d](/filings/0001476204-24-000111.md) | [35.4 d](/filings/0001476204-26-000005.md) | [36.0](/filings/0001476204-25-000065.md) | [24.0 d](/filings/0001476204-25-000092.md) | [48.6 d](/filings/0001476204-25-000108.md) | [25.4 d](/filings/0001476204-26-000005.md) | [51.5](/filings/0001476204-26-000024.md) | [38.8 d](/filings/0001476204-26-000032.md) | [39.5 d](/filings/0001476204-25-000108.md) | [27.4 d](/filings/0001476204-26-000005.md) | [54.7](/filings/0001476204-26-000024.md) | [41.2 d](/filings/0001476204-26-000032.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: not reported

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [132](/filings/0001476204-23-000129.md) | [132](/filings/0001476204-24-000055.md) | [132](/filings/0001476204-24-000099.md) | [133](/filings/0001476204-24-000111.md) | [136](/filings/0001476204-25-000065.md) | [136](/filings/0001476204-25-000092.md) | [137](/filings/0001476204-25-000108.md) | [139](/filings/0001476204-26-000024.md) | [139](/filings/0001476204-26-000032.md) | [139](/filings/0001476204-25-000108.md) | [139](/filings/0001476204-26-000024.md) | [139](/filings/0001476204-26-000032.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 128,700,000 at 2026-07-17, from the cover of the [10-Q filed 2026-07-24](/filings/0001476204-26-000032.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:40 ET. No prices; not investment advice.